LDS/Medical Tests/Connective Tissue Disease Profile (Extractable Nuclear Antigen Antibody Panel)

Connective Tissue Disease Profile (Extractable Nuclear Antigen Antibody Panel)

Connective tissue diseases (CTD) are systemic autoimmune diseases characterized by autoantibodies directed towards connective tissues. The connective tissues are present in every organ of the body, including skin, major internal organs, brain, joints, etc. When an autoimmune reaction occurs and targets the connective tissues, inflammatory changes in the blood vessels and other connective tissues develop, which then results in tissue damage. Connective tissue diseases can be hereditary, but many are acquired. Normally, when the antinuclear antibody (ANA) is positive, this is the first sign of a CTD. The most common CTD is Systemic Lupus Erythematosus (SLE).

This panel can detect anti-nuclear antibody, anti-double stranded DNA, anti-SSA, anti-SSB, anti-Smith, anti-Smith/RNP, anti-Scl-70, anti-Jo-1, anti-ribosomal and anti-centromere antibodies, Complement profile, Rheumatoid factor, Cryoglobulins, anti-phospholipid antibody, ANCA, anti-nucleolar RNA antibody and anti-sn RNP. For more see Autoantibody Panel.

Antibodies known as anti-double stranded DNA (anti-dsDNA) are most frequently detected and are the most specific marker of SLE. Other antibodies that may be present in SLE are anti-SSA, anti-SSB, anti-Smith antibodies, and anti-ribosomal antibodies. Other CTDs include rheumatoid arthritis, scleroderma, and dermatomyositis. Many CTDs are not diagnosed immediately because all symptoms may not be present or serious enough to determine the actual disease. They are usually differentiated in later stages when symptoms are present.

  • Diagnosis of systemic lupus erythematosus
  • Diagnosis of rheumatoid arthritis
  • Diagnosis of scleroderma, polymyositis and dermatomyositis
  • As an aid in diagnosis of Sjogren syndrome
  • As an aid in diagnosis of vasculitis
  • CREST syndrome

Increased in:

  • Systemic Lupus Erythematosus
  • Sjogren syndrome
  • Scleroderma
  • Polymyositis
  • Dermatomyositis
  • Vasculitis
  • Marfan’s syndrome
  • CREST syndrome
  • Rheumatoid Arthritis
  • Nephrotic syndrome

Negative (No Antibody Detected)
 

 

Semi-quantitative homogeneous fluorescent-based microparticles immunoassay using flow cytometry readings (multiplex immunoassay using bead array), ELISA.

Serum (SST) or plasma (EDTA).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days 
  • Frozen: 30 days

 

Complete Blood Count, ESR, C-Reactive Protein, Extractable Nuclear Antigen Antibodies, Double Stranded DNA Antibody, Antiphospholipid Antibody, ANA by IFA, Renal function tests, Creatinine, BUN.
3-4 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Clin Med Res. 2005 Aug;3(3):190-3. [PMID: 16160075]
  • Dermatol Clin. 1994 Jan;12(1):161-73. [PMID: 8143379]
  • Am Fam Physician. 2003 Dec 1;68(11):2179-86. [PMID: 14677663]
  • Clin Exp Rheumatol. 1997 Jul-Aug;15(4):457-65. [PMID: 9272315]
  • Autoimmun Rev. 2007 Jun;6(6):334-40. [PMID: 17537377]
  • Biomed Pharmacother. 2006 Dec;60(10):648-55. [PMID: 17064873]
  • Clin Rheumatol. 1990 Mar;9(1 Suppl 1):100-10. [PMID: 2203588]
  • Mayo Clin Proc. 1995 Feb;70(2):183-4. [PMID: 7845044]
  • Turgeon, Mary L., 1990. Immunology and serology in laboratory medicine. The C.V. Mosby Company. St. Louis, Missouri.